Background-Activation of innate immunity, especially infiltration of monocytes, is critical for proper wound healing and scar formation after myocardial infarction (MI). Therefore, we tested the hypothesis that interleukin-13 (IL-13), which influences the differentiation of monocytes/macrophages and has profibrotic properties, modulates wound healing and remodeling after MI. Methods and Results-MI was induced by permanent ligation of the left coronary artery in both male and female wildtype (WT)/IL-13 −/− mice. Real-time polymerase chain reaction demonstrated that expression of IL-13 was induced in left and right ventricular myocardium of WT mice within days in response to MI. Fifty-six-day survival was significantly impaired (65% in WT versus 34% in IL-13 −/− ) in male but not female IL-13 −/− (55% in WT versus 54% in IL-13 −/− ) mice. Serial echocardiography showed significantly increased left ventricular dilation in male IL-13 −/− compared with WT mice starting from day 1 after MI, despite comparable infarct size. Fluorescence-activated cell sorter analysis revealed less leukocyte infiltration in male IL-13 −/− mice on day 3. Real-time polymerase chain reaction analysis demonstrated reduced expression of marker genes of alternative activation in monocytes sorted from the infarct zone of male IL-13 −/− in comparison with WT mice on day 3 after MI. Conclusions-Genetic deficiency of IL-13 worsens outcome after MI in male mice. Our data indicate that IL-13 regulates leukocyte recruitment and induces M2-like monocyte/macrophage differentiation, which modifies wound healing within the infarct zone. (Circ Heart Fail. 2014;7:822-830.) 
M yocardial infarction (MI) is the most common and clinically most significant form of acute cardiac injury and results in considerable morbidity and mortality in Western world. 1 Necrosis of myocardial tissue elicits an inflammatory response, which is mainly based on innate immune mechanism. Coordinate infiltration of leukocytes is a prerequisite for clearance of necrotic cells and matrix debris, formation of a capillary-rich granulation tissue, and final replacement by a collagenous scar. The important role of immunity for cardiac wound healing has long been recognized, and innate immune activation mechanisms have been studied in detail. [2] [3] [4] Monocytes/macrophages have been identified as pivotal cellular effectors during myocardial wound healing. 5, 6 
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Immunity also affects chronic remodeling of the remaining viable myocardium, which manifests as left ventricular (LV) dilation, interstitial fibrosis, and cardiomyocyte hypertrophy leading to progressive deterioration of myocardial function. 3 Remodeling is mainly determined by the initial infarct size; however, dysfunctional wound healing might also significantly contribute.
Besides innate immunity, adaptive immunity becomes activated by MI. 7 Recently, we could demonstrate that T-cell receptor-dependent activation of CD4 + T cells is a prerequisite for proper wound healing after MI. 8 The differentiation of CD4 + T cells is characterized by their cytokine expression portfolio. Besides interleukin-4 and -5, interleukin-13 (IL-13) is the most important cytokine expressed by Th2-polarized CD4 + T cells. 9 Besides the antigen-specific Th2 response, accumulating evidence from several recent experimental studies indicates involvement of innate immune cells 10 in both expression of IL-13 and initiation of Th2 responses. 11, 12 Previously, it was also reported that cardiomyocytes themselves are able to express IL-13 in response to angiotensin-II or mechanical stretch. 13 Especially, the pivotal role of IL-13 in the pathophysiology of allergy and helminth defense is well established. 14, 15 It classically modulates differentiation and function of monocytes and B cells via the interleukin-13Rα1 receptor. 16 When paired with the interleukin-4Rα, the heterodimer receptor binds IL-13 with high affinity, which mainly initiates transcription by translocation of activated Stat6 to the nucleus. 17 By this signal transduction pathway, IL-13 induces alternative macrophage differentiation, which is characterized by upregulation of proteins such as mannose receptor, interleukin-10, transforming growth factor-β, and arginase. 18 The latter proteins are specifically involved in scar formation and fibrosis. Besides its effect on macrophage differentiation, IL-13 itself has been long recognized as a potent profibrotic mediator. Its profibrotic activity involves both transforming growth factorβ-dependent 19, 20 and -independent downstream pathways. 21 Collagen de novo formation within infarct zone and pathological fibrosis in the viable myocardium are processes modulated by monocytes. They contribute essentially to post-MI repair and remodeling. 3 Furthermore, it was reported recently that increased serum levels of IL-13 can be found in patients with heart failure. 22 This prompted us to hypothesize that IL-13 is involved in cardiac wound healing and remodeling after MI. Here, we report that IL-13 expression contributes to the differentiation of monocytes within the myocardium and improves survival early after experimental MI in mice.
Methods

Animals
Animals were maintained ≥2 weeks for acclimatization with free access to standard diet and water. All mice were kept under specific pathogen-free conditions. Eight-to 10-week-old wild-type (WT) BALB/c and IL-13 −/− mice 23 on the same genetic background were used for the experiments. Genotyping of IL-13 −/− mice was performed as recently described. 23 CD4 knockout mice (stock Nr. 002663) and WT controls, both on a C57/B6 background, were purchased from Jackson laboratories.
The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health. All animal procedures were approved by the local government.
Infarct Model
MI was induced in mice as described previously. 24 In brief, mice were anaesthetized with isoflurane, intubated, and put on a mechanical small animal ventilator. After a left-sided thoracotomy, MI was induced by ligating the proximal portion of the left coronary artery. Buprenorphin was given intraperitoneally for analgesia. In parallel subgroups, thoracotomy was performed to expose the heart, but no suture was made to the coronary artery (sham operation).
Study Protocol, Infarct Size Definition
For all analysis except echocardiography, mice were euthanized at the indicated time points. For analysis of LV remodeling, echocardiography was performed repeatedly for 56 days in 12 male/8 female WT and 13 male/6 female IL-13 −/− mice. These mice were euthanized at day 56, and infarct size was determined. Mice with infarct sizes <30% were excluded from all analyses. The infarct size was determined either by light microscopic analysis of picrosirius red-stained sections (on day 7, 56), as recently described, 24 or by determination of the infarct/LV weight ratio after weighing the dissected infarct zone and the residual LV (day 3). Additional sets of WT and IL-13 −/− mice were randomly assigned to the specified molecular analyses and euthanized at day 3, 7, and 56. Survival analysis includes all mice which met the inclusion criteria (based on infarct size at the time of euthanization).
Echocardiography
Echocardiography was performed on a Toshiba Aplio system with a 15-MHz ultrasound probe under light anesthesia with isoflurane (≈1.5 vol. %) under spontaneous respiration. 24 Short axis 2-dimensional echocardiographic images acquired at the midpapillary and apical levels of the LV were stored as digital loops. LV end-systolic and end-diastolic areas were calculated by manual tracings of the endocardial border followed by planimetry with the Nice software package (Toshiba Medical Systems). Simultaneous transversal M-mode tracings were recorded with the cursor placed in the middle of the LV cavity to determine diameters on papillary and apical levels.
Fluorescence-Activated Cell Sorter Analysis
Cell suspensions from individual hearts were prepared by digestion with collagenase type 2 and protease type XIV (Sigma Aldrich, Germany) as has recently been described. 8, 25 For more details on antibodies used, see methods in the Data Supplement.
Cell Sorting and RNA Preparation for Gene Expression Analysis
Myocardial CD45 + CD11b + Ly6G − cells were sorted from single cell suspensions from the LV infarct zone on a FACSAria III cell sorter (BD Biosciences, Franklin Lakes, NJ). Purity was always >95%. Typically, ≈400 cells/heart were sorted, collected in 300 μL RLT/dithiothreitol (DTT) buffer (980 μL RLT+20 μL DTT [2 mol/L]), and immediately frozen in liquid nitrogen. RNA isolation was performed according to the manufacturer's protocol (Rneasy Micro Kit, Qiagen, Hamburg, Germany). For quantitative real-time polymerase chain reaction (rt-PCR), gene expression was normalized to the GAPDH RNA content. RNA was than amplified by according to the protocol of the TRinucleotide mRNA amplification Nano kit (AmpTec, Hamburg, Germany).
Gene Expression Analysis
RNA isolation and rt-PCR procedures were performed with commercially available TaqMan probes (Applied biosystems, Foster City, USA) as reported previously. 24 For quantitative rt-PCR, gene expression was normalized to the 18S RNA content. IL-13 expression is reported as relative to expression in phorbol 12-myristate 13-acetate (PMA)/Ionomycin-stimulated splenocytes. The 2 −ΔΔCT method using 18S RNA and splenocytes expression levels as the reference and calibrator, respectively, was used for relative quantification of gene expression.
In Vitro Restimulation Assays
Single cell suspensions from infarct/ infarct boarder zones were prepared as described above, and 10 6 cells were restimulated for 4 hours with recombinant interleukin-25, interleukin-33 (eBioscience, Frankfurt, Germany), or PMA (500 ng/mL, Calbiochem distributed by Merck, Darmstadt, Germany)+Ionomycin (5 ng/mL, Sigma Aldrich, Munich, Germany) in standard RPMI cell culture medium.
Histological Analysis
Histological techniques including collagen quantification are described in the methods section in the Data Supplement.
Collagenase Activity
Matrix metalloproteinase (MMP) activity was assessed with Omni-MMP fluorogenic substrate (BML-P126-0001, Enzo Life Sciences, Lörrach, Germany). Three days after MI induction, myocardial tissue was homogenized in 250 μL ice-cold buffer (50 mmol/L HEPES, 10 mmol/L CaCl 2 , 10 μmol/L ZnCl 2 , 0,05% Brij-35, pH, 7). Samples were centrifuged (13 000 rpm, 4°C, 10 minutes), and the supernatant was collected. Fifty micrograms of protein was incubated in the presence of 10 μmol/L substrate in a 96-well plate. Kinetic fluorescence measurements were performed with a microplate reader (excitation of 328 nm, emission of 393 nm) at 37°C for 3 hours.
Statistical Analysis
Results are presented as mean±SE per group if not otherwise stated. Nonparametric data are presented as median±range. For single comparison of data, independent groups were compared by an unpaired t test if not otherwise indicated. Single comparisons of nonparametric data are analyzed by a Mann-Whitney U test. For multiple comparisons, the Kruskal-Wallis test was performed, and for analysis of repeated measurements, the Friedman Test with Dunn post hoc test was performed if not otherwise stated. Survival data were shown as Kaplan-Meier curves, and data were analyzed by a log-rank test. Differences were considered significant at P<0.05. Data analysis was performed by GraphPad Prism 4 statistics program.
Results
IL-13 Is Expressed in Myocardium in Response to MI
We first determined by quantitative rt-PCR whether IL-13 is expressed in myocardium after MI. In sham-operated hearts, the signal was below threshold, whereas it became detectable from day 1 after MI on. Within the infarct zone, IL-13 expression peaked on day 3, declined thereafter until day 7, and then again increased until day 56. IL-13 expression in intact, right ventricular myocardium also transiently increased after MI ( Figure 1A ). Myocardial IL-13 expression on day 7 was further not significantly different between male and female mice ( Figure 1B ). Comparable IL-13 expression could be demonstrated in infarcted mice both on a BALB/c and C57BL/6 background (data not shown). Serum IL-13 levels were nonsignificantly elevated in male MI compared with sham animals on day 7 (Figure IA in the Data Supplement).
Angiotensin-II is upregulated after MI and induces IL-13 expression in cardiomyocytes in vitro. To study the significance of angiotensin-II for IL-13 expression after MI, we treated WT mice with the angiotensin-II receptor blocker losartan for 7 days. Losartan treatment modestly reduced myocardial IL-13 expression ( Figure 1C ) and IL-13 serum levels ( Figure IB in the Data Supplement) on day 7, indicating that angiotensin stimulation or mechanical load of the LV, which is also reduced by losartan, contributes to IL-13 expression in response to MI.
Next, we tried to determine the cellular source of IL-13 after MI by different approaches. Unfortunately, immunohistology did not allow attributing IL-13 expression to a distinct cell type because of low signal intensity. Because IL-13 is mainly a CD4 + T-cell-derived cytokine, we first studied whether IL-13 expression was also detectable in CD4 knockout mice, which lack CD4 + T cells. Interestingly, both on day 7 and 56, there was no significant difference in IL-13 expression between WT and CD4 −/− mice ( Figure 1D ), indicating that CD4 + T cells are not the main source of IL-13 expression.
As an alternative source, IL-13 might also be produced by innate leukocytes infiltrating the myocardium. We, therefore, analyzed intracellular IL-13 expression in leukocytes derived from dispersed infarct zones. Fluorescence-activated cell sorter analysis was not able to detect intracellular IL-13 protein expression in both CD45 + leukocytes and CD45 − nonleukocytes. When single cell suspensions prepared from infarct zones were restimulated by PMA/Ionomycin in vitro, we could reproducibly detect a small population of CD45 + leukocytes that expressed IL-13 ( Figure 2 ). We next examined whether interleukin-25 and -33, as known stimulators of IL-13 expression released in response of cell injury, were able to induce IL-13 expression in leukocytes isolated from infarct zone. Both interleukin-25 and IL-13 reproducibly induced IL-13 in CD45 + leukocytes to a similar extend as did PMA/Ionomycin ( Figure 2) .
The heart-derived leukocyte population expressing IL-13 in response to PMA/Ionomycin, interleukin-25, or interleukin-33 restimulation was further characterized by cell surface marker staining. The IL-13 + cells did neither express CD3 nor NK1.1, making a T cell, NK cell, and NK-T cell origin unlikely. The myocardial IL-13 + leukocytes were negative for the stem cell growth factor receptor c-kit, which is expressed on mast cells and progenitor cells. Furthermore, they did not express the IgE receptor FcεRI, which can be found on basophils and mast cells. The subset of IL-13 + leukocytes was characterized by absence of Ly6G surface expression and positive staining for CD11b indicating myeloic origin ( Figure 2 ).
Together, our results outline that expression IL-13 gets upregulated both in myocardium and serum in response to MI and originates from different cellular sources including myeloic cells.
IL-13 −/− Deficiency Has Sex-Specific Effects on Clinical Outcome After MI
At baseline, WT and IL-13 −/− mice showed no difference in LV function and diameter ( Table II in the Data Supplement). We next induced permanent MI in both male and female WT and IL-13 −/− mice and followed them for ≤56 days for assessment of the functional significance of IL-13 expression in response to MI. After induction of MI by permanent ligation of the left coronary artery, there was significantly worse survival in male IL-13 −/− (34% survival after 56 days) compared with WT mice after MI (65% survival after 56 days; Figure 3A ). Increased mortality in male mice was especially evident during the first week after MI. Myocardial rupture did not significantly contribute to the differences observed in early mortality between male WT and IL-13 −/− mice because only 1 LV rupture was found in male IL-13 −/− mice. Infarct size on day 3 was not significantly different between male IL-13 −/− (52.0±4.9%) and male WT (46.7±8.8%, Table) . In female mice, IL-13 deficiency did not affect 56-day survival (IL-13 −/− 54% versus WT 55% survival). Irrespective of sex, in both genotypes, the apical end-diastolic diameter representing the area of infarction progressively increased and the fractional shortening decreased in infarct compared with sham-operated mice ( Figure 3B and 3C ). Echocardiographic analysis of mice with infarct size ≥30% which typically show LV remodeling after MI revealed significantly increased LV dilation in male IL-13 −/− compared with male WT mice both on the apical ( Figure 3B ) and on the papillary level representing the infarct border zone as well (Table III in the Data Supplement). Of note, LV diameter was already significantly increased in male IL-13 −/− 1 day after MI. Accordingly, fractional shortening and lung weight/ body weight ratios at 56 days tended to be increased in male IL-13 −/− compared with WT (Table) . In analogy to the survival data, there was no effect of IL-13 deficiency on LV remodeling in female mice.
Collectively, these data indicate that IL-13 deficiency impairs the outcome after MI in male mice but not female mice. Therefore, we concentrated our further analysis on male mice
IL-13 Determines Monocytes/Macrophage Differentiation Within Myocardium
To study whether expression of IL-13 modifies expression of inflammatory mediators, we analyzed cytokine, chemokines, and growth factor protein expression in the infarct/ infarct boarder zone of male WT and IL-13 −/− mice. Because differences LV geometry and survival became evident early after MI, the analysis was performed on day 3. Several chemokines and cell adhesion surface molecules were lower expressed in male IL-13 −/− than in WT mice, indicating that IL-13 expression might regulate leukocyte recruitment ( Table IV in , and VCAM-1 (vascular cell adhesion molecule 1) were >2-fold higher expressed in WT mice, whereas the Ly6C low monocytes attracting chemokines fractalkine (CX3CL1) was found to be lower expressed in WT. Furthermore, 2 monocyte-expressed proteins well known for their important role in postmyocardial wound healing, MMP-9, and insulin-like growth factor-1 were >2-fold more abundant in WT mice.
We next analyzed leukocytes within the scar/scar boarder zone on day 3 by fluorescence-activated cell sorter analysis. Total number of CD45 + cells per mg tissue was significantly lower in male IL-13 −/− than in WT mice (Figure 4 ). Ly6G + neutrophils and Ly6C high monocytes/macrophages constitute the predominant leukocyte subsets within the infarcted myocardium on this time point. The absolute number of monocytes/ macrophages was not significantly different between genotypes because of a relatively increased proportion of cells within the Ly6G − gate in IL-13 −/− mice (31% versus 57%; P=0.079) comprising of monocytes and macrophages. The relative proportion of Ly6C high versus Ly6C low cells was also not different (data not shown).
To assess further their local differentiation status, we sorted CD11b + Ly6G − bona fide monocytes/macrophages for gene expression analysis. By rt-PCR, several marker genes of classical (tumor necrosis factor-α, cathepsin K) and alternative macrophage activation (YM-1, osteopontin, coagulation factor XIII, MMP-9, arginase-1, CD206) were differentially expressed in sorted monocytes/macrophages (Figure 4 ), whereas iNOS (inducible NO-synthase) expression, a marker gene of M1 macrophages was not detectable. Collectively, IL-13 modulates early recruitment and differentiation of heart infiltrating monocytes inducing an M2-like activation state.
Effect of IL-13 Deficiency on Collagenase Activity and Collagen De Novo Expression
Wound healing is characterized by balanced extracellular collagen matrix degradation and de novo collagen synthesis within the capillary-rich granulation tissue which replaces the necrotic myocardium. There was no difference between WT and IL-13 −/− in capillary density on day 3 within the infarct border zone mainly representing angiogenesis. On day 56, vessel density within the intact septal myocardium was also not different between genotypes ( Figure IIA and IIB in the Data Supplement). Despite decreased pro-MMP-9 expression in sorted monocytes (Figure 4 ) and tissue homogenates (Table IV in tha Data Supplement) from IL-13 −/− mice total collagenase activity within the infarct zone did not differ between WT and IL-13 −/− mice on day 3 ( Figure 5A ). Furthermore, expression of procollagens I and III as quantified by rt-PCR was not significantly different between genotypes on day 3 ( Figure 5B ). By day 7, in both genotypes, there was a well-aligned collagen network ( Figure 5C ). However, quantitative collagen analysis based on picrosirius red-stained sections ( Figure III in the Data Supplement) revealed a significantly increased collagen deposition within the scar zone of IL-13 −/− compared with WT mice on day 7 ( Figure 5D ). Accordingly, collagenase activity in the infarct zone of WT mice was significantly higher than in IL-13 −/− mice on day 7 ( Figure 5E ).
Collectively, our findings indicate that increased LV dilation is associated with increased collagen fiber area and attenuated collagenase activity in IL-13 −/− mice surviving until day 7. P>0.05 for comparisons between genotypes (n=3-10). BW indicates body weight; IL-13, interleukin-13; LV, left ventricle; MI, myocardial infarction; and WT, wild type.
Discussion
Myocardial IL-13 Expression in Response to MI
Our results show for the first time that IL-13 is expressed in the myocardium in response to MI. Myocardial IL-13 expression starts at day 1 after MI. Both the observation of a partial inhibition by an angiotensin receptor blocker and the biphasic LV expression pattern indicates that, besides angiotensin, mechanical load might be a stimulus for local IL-13 expression. Angiotensin and stretch-dependent IL-13 expression was reported for cardiomyocytes in vitro. 13 Our in vitro restimulation experiments indicate that a small population of CD11b + myeloid cells might also contribute to the early IL-13 expression in myocardium. A potential homologous human cell population was recently described as IL-13-expressing CD14 dim CD16 + monocytic cells in the peripheral blood of patients with heart failure. 26 Especially during the late peak, Th2-polarized CD4 + T cells might partially contribute to IL-13 expression, whereas during the early phase after MI, CD4 + T cells do not significantly contribute to IL-13 expression as indicated by comparative gene expression analysis in WT and CD4 knockout mice. This is in accordance with our previous finding that heart infiltrating T cells during the first week after MI mainly show a Th1 cytokine profile. 8
Sex-Dependent Functional Relevance of IL-13 Expression After MI
The functional relevance of IL-13 for wound healing was further studied in mice with genetic deficiency of IL-13. Male IL-13 −/− mice showed increased LV dilation and worse survival which was not evident in female mice. Decreased LV function and consecutively increased lung/body weight ratio indicate that male IL-13 −/− mice are more prone to experience heart failure. It is a limitation of the present study that we cannot determine the number of animals which died because of arrhythmic events because we did not perform continuous ECG monitoring. On , we rigorously performed necropsy in all animals which have died after MI and could not find a difference in the prevalence of LV rupture which was comparatively low in all groups.
Effect of IL-13 Deficiency on Monocytes Differentiation
Genetic deficiency of IL-13 modulated the gene expressions signature of monocyte/monocyte-derived cells in myocardium of male mice without changing the proportion of the Ly6C high / Ly6C low subsets. The 2 subsets of monocyte-derived cells that can be differentiated by Ly6C surface expression can be found in infarcted myocardium. 6, 27, 28 First, proinflammatory Ly6C high monocytes preferentially migrate to the myocardium and constitute the predominant subset within the first 3 days after MI. In a second phase, Ly6C low cells differentiate in the myocardium, which secrete anti-inflammatory cytokines and growth factors thus promoting granulation tissue formation. Any experimental means to change this balance, for example, by depletion of either subset, was shown to impair wound healing, induce LV thrombus formation, 29 and aggravate LV dilation and mortality, indicating a central role of monocytes or monocyte-derived cells as cellular effectors of wound healing. 5 The gene expression pattern we observed in monocytes/ macrophages from WT versus IL-13-deficient mice does not closely resemble that of conventional and alternatively activated macrophages. This might partially rely on the fact that we analyzed a mixed population of CD11b + Ly6G − cells, which contains different differentiation stages of monocytes/ macrophages. However, the concept of macrophage polarization is mainly based on in vitro stimulation experiments. Functional skewing of monocytes and monocyte-derived macrophages under inflammatory conditions in vivo is certainly more complex, and steady recruitment of monocytes implies a coexistence of cells in different activation and differentiation states. Thus, we think that analysis of monocytes/macrophage gene expression in a more heterogeneous population of cells derived from in vivo disease models, as done by fluorescence-activated cell sorter in the present work, allows better understanding of the differentiation and functional role of monocyte-derived cells in vivo. 30
Functional Effect of M2-Like Monocytes Differentiation on Infarct Healing
Mechanisms to regulate the intramyocardial differentiation of monocytes and their effect on wound healing have not yet been addressed in detail. However, there is experimental evidence that alternative activation toward an M2-like differentiation status is necessary for functional myocardial healing after MI. Troidl et al 31 analyzed the gene expression status of myocardial monocytes/macrophages after MI and demonstrated that genes associated with the classical activation pattern are strongly transcribed early after MI. Within the first days after MI, they described a change in gene expression from proinflammatory toward an alternative activation signature. 31 The functional significance for this shift toward an alternative differentiation status was demonstrated by an experimental approach to induce alternative activation by phosphatidylserine presenting liposomes. Treatment of rats after MI attenuated LV dilation and remodeling after MI. 32 Correspondingly, mice lacking the class A scavenger receptor which contributes to M2 macrophage polarization showed aggravated LV dilation and reduced ventricular function after MI. 33 In conclusion, albeit the exact mechanism is not yet clear, differentiation of infiltrating monocytes toward an alternative macrophage phenotype during wound healing obviously beneficially affects the outcome after MI.
Effect on IL-13 Deficiency Extracellular Matrix Turnover
On day 1, when mortality was not yet different between genotypes, infarct sized tended to be increased in IL-13 −/− mice, indicating that more pronounced early infarct expansion takes place when IL-13 expression is absent. By gene expression screening, we found reduced MMP-9 expression in IL-13 −/− mice. Total collagenase activity on day 3 was not different between genotypes, however. Traditionally, MMP-9 is considered an enzyme that degrades extracellular matrix and contributes to worse outcome after MI, which is mainly derived from the observation that mice with a global genetic deficiency of MMP-9 show improved outcome after MI. 34 Besides other cellular sources, MMP-9 is preferentially expressed in M2-over M1-polarized macrophages. In IL-13 −/− mice, MMP-9 expression was reduced in monocytes. The functional effects of MMP-9 expression in heart infiltrating monocytes might obviously differ from a global MMP-9 inhibition. MMP-9 overexpression in monocytes attenuated early LV dilation and improved LV function after MI. 35 Accordingly, macrophage M2 polarization and MMP-9 expression was demonstrated to be reduced in MMP-28-deficient mice, which was associated with less collagen cross-linking, increased early LV dilation, and mortality after MI. 36 IL-13 contributes to pathological fibrosis in several disease models by direct effects on myofibroblast collagen expression. 19, 20, 37 In the myocardium, IL-13 contributes to the aging-related increase in extracellular collagen deposition. 38 In contrast to this, we found no effect of IL-13 deficiency on collagen de novo expression on day 3. In surviving IL-13 −/− mice, even reduced collagenase activity and increased scar collagen deposition were found on day 7, which might be best explained by preferential mortality of IL-13 −/− mice with initially large infarcts and dysfunctional infarct expansion in comparison with WT mice.
In conclusion, we could demonstrate that genetic deficiency of IL-13 leads to increased leukocyte infiltration and reduced M2-like differentiation of the monocytes in the myocardium which is associated with a sex-specific effect on clinical outcome after MI. Our data thus indicate that in contrast to other disease models of pathological fibrosis where Th2-cellderived IL-13 induces overt collagen deposition by directly inducing myofibroblast collagen deposition, the beneficial effect after MI is rather mediated by modulation of innate inflammation, especially promoting the shift in monocytes differentiation from proinflammatory (M1-like) to M2-like.
